ERYTECH provides business update and financial results for the full year 2013 Post author:admERY Post published:April 29, 2014 Post category:Newsroom ERYTECH provides a business update and reports its financial results for the period ending December 31, 2013. You Might Also Like ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia June 24, 2018 ERYTECH Presents New Preclinical Anti-Tumor Data on erymethionase at AACR 2017 March 20, 2017 ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML December 8, 2017
ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia June 24, 2018
ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML December 8, 2017
